|
Myasthenia Gravis
|
C10.668.758.725 |
|
|
Tuberculosis, Meningeal
|
C01.150.252.223.500.937 |
|
|
Homes for the Aged
|
N02.278.825.462 |
|
|
Cyclin-Dependent Kinase Inhibitor p57
|
D12.776.167.187.700 |
|
|
Cyclin-Dependent Kinase Inhibitor Proteins
|
D12.776.167.187 |
|
|
Epigenomics
|
H01.158.273.180.350.074 |
|
|
Genomics
|
H01.158.273.180.350 |
|
|
Plastination
|
D000077780 |
[Preservation technique in which epoxy polymers are used to preserve tissue or an organ resulting in anatomically authentic dry specimens often used in teaching of anatomy.
] |
|
Vertebrates
|
B01.050.150.900 |
|
|
Gelsolin
|
D12.776.220.525.350 |
|
|
Axitinib
|
D000077784 |
[A benzamide and indazole derivative that acts as a TYROSINE KINASE inhibitor of the VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR. It is used in the treatment of advanced RENAL CELL CARCINOMA.
] |
|
Visible Human Projects
|
J01.897.280.500.545.129.805 |
|
|
Fruit Proteins
|
G07.203.300.428.920.113 |
|
|
Tenecteplase
|
D000077785 |
[A tissue plasminogen activator enzyme that acts as a fibrinolytic agent; it is used for the dissolution of blood clots, such as those that occur in acute MYOCARDIAL INFARCTION.
] |
|
Torsemide
|
D000077786 |
[A pyridine and sulfonamide derivative that acts as a sodium-potassium chloride symporter inhibitor (loop diuretic). It is used for the treatment of EDEMA associated with CONGESTIVE HEART FAILURE; CHRONIC RENAL INSUFFICIENCY; and LIVER DISEASES. It is also used for the management of HYPERTENSION.
] |
|
United States Agency for Healthcare Research and Quality
|
I01.409.418.750.600.650.592 |
|
|
Edar-Associated Death Domain Protein
|
D12.644.360.024.500.061 |
|
|
Arsenic Trioxide
|
D01.075.038 |
|
|
Vietnam Conflict
|
I01.880.735.950.250.937 |
|
|
Osteosarcoma, Juxtacortical
|
C04.557.450.565.575.650.655 |
|
